Comparative Clinical Trials of Botulinum Toxins

Botulinum Toxin: Therapeutic Clinical Practice and Science

Volumn , Issue , 2009, Pages 398-405

  Dressler, Dirk ^a   Comella, Cynthia ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72849108851     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4928-9.00033-0     Document Type: Chapter

References (22)

1. Schantz E, Johnson E Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med 1997, 40:317-327.
2. Sampaio C, Costa J, Ferreira JJ Clinical comparability of marketed formulations of botulinum toxin. Mov Disord 2004, 19(suppl 8):S129-S136.
3. Lim EC, Seet RC Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurol Scand 2008, 117:73-84.
4. Schantz E, Kautter D Microbiological methods: Standardized assay for clostridium botulinum toxins. J Assoc Official Analytical Chemists 1977, 61:96-99.
5. Pearce LB, Borodic GE, First ER, MacCallum RD Measurement of botulinum toxin activity: evaluation of the lethality assay. Toxicol Appl Pharmacol 1994, 128:69-77.
6. Jankovic J Botulinum toxin therapy for cervical dystonia. Neurotox Res 2006, 9:145-148.
7. Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 2005, 64:1949-1951.
8. Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 1998, 64:13-17.
9. Lew MF, Brashear A, Factor S The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology 2000, 55(suppl 5):S29-S35.
10. Sloop RR, Cole BA, Escutin RO Human response to botulinum toxin injection: type B compared with type A. Neurology 1997, 49:189-194.
11. Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1. Mov Disord 1997, 12(6):1013-1018.
12. Nüssgens Z, Roggenkamper P Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol 1997, 235:197-199.
13. Roggenkämper P, Jost WH, Bihari K, Comes G, Grafe S Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 2006, 113:303-312.
14. Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005, 65:1423-1429.
15. Consky E, Lang AE Clinical Assessments of Patients with Cervical Dystonia 1994, Marcel Dekker, New York.
16. Dressler D, Benecke R Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 2003, 49:34-38.
17. Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology 2005, 65:765-767.
18. Pappert EJ, Germanson T Botulinum toxin type B vs. type A in toxin-naive patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Mov Disord 2007.
19. Bihari K Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Curr Med Res Opin 2005, 21:433-438.
20. Odergren T, Hjaltason H, Kaakkola S, Solders G, Hanko J, Fehling C, et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 1998, 64:6-12.
21. Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 2002, 72:459-462.
22. Dressler D, Rothwell JC Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle. Eur Neurol 2000, 43:13-16.